SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-086361
Filing Date
2007-11-30
Accepted
2007-11-30 17:11:39
Documents
10
Period of Report
2007-11-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-30396_18k.htm 8-K 37096
2 EX-3.1 a07-30396_1ex3d1.htm EX-3.1 55001
3 EX-10.1 a07-30396_1ex10d1.htm EX-10.1 57994
4 EX-10.2 a07-30396_1ex10d2.htm EX-10.2 69364
5 EX-10.3 a07-30396_1ex10d3.htm EX-10.3 72686
6 EX-10.4 a07-30396_1ex10d4.htm EX-10.4 46195
7 GRAPHIC g303961mc01i001.jpg GRAPHIC 2415
8 GRAPHIC g303961mc01i002.jpg GRAPHIC 2417
9 GRAPHIC g303961me01i001.jpg GRAPHIC 2415
10 GRAPHIC g303961me01i002.gif GRAPHIC 73
  Complete submission text file 0001104659-07-086361.txt   350738
Mailing Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14732 | Film No.: 071278667
SIC: 2835 In Vitro & In Vivo Diagnostic Substances